Inhibition of lipopolysaccharide-induced interferon regulatory factor 3 activation and protection from septic shock by hydroxystilbenes

被引:28
作者
Dang, O
Navarro, L
David, M
机构
[1] Univ Calif San Diego, Dept Biol, Div Biol Sci, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, USCD Canc Ctr, La Jolla, CA 92093 USA
来源
SHOCK | 2004年 / 21卷 / 05期
关键词
IRF3; LPS; sepsis; piceatannol; IL-6; TF; ISG; interferon;
D O I
10.1097/00024382-200405000-00012
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Interferon regulatory factor 3 (IRF3) mediates the transcriptional induction of interferon-stimulated genes (ISGs) in response to viral and bacterial infections. Here we show that the hydroxystilbene piceatannol inhibits the LIPS-mediated activation of IRF3 and subsequent ISG induction. Consequently, piceatannol blocks the LPS-induced up-regulation of critical mediators of the inflammatory response such as interleukin 6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), intercellular adhesion molecule 1 (ICAM-1), and macrophage chemoattractant protein (MCP-1). Furthermore, the LIPS-mediated induction of tissue factor (TF), a cell surface protein responsible for initiating the coagulation cascade, is also inhibited by piceatannol. The effectiveness of piceatannol in blocking both the inflammatory response and the coagulation pathway is evidenced by its ability to confer protection against LPS-induced septic shock in a murine model. Thus, IRF3 appears to be a promising target for pharmacologic intervention in the prevention or treatment of septic shock syndrome.
引用
收藏
页码:470 / 475
页数:6
相关论文
共 33 条
[1]   The immunopathogenesis of sepsis [J].
Cohen, J .
NATURE, 2002, 420 (6917) :885-891
[2]  
David M, 2002, BIOTECHNIQUES, P58
[3]   IRF3 mediates a TLR3/TLR4-specific antiviral gene program [J].
Doyle, SE ;
Vaidya, SA ;
O'Connell, R ;
Dadgostar, H ;
Dempsey, PW ;
Wu, TT ;
Rao, G ;
Sun, R ;
Haberland, ME ;
Modlin, RL ;
Cheng, G .
IMMUNITY, 2002, 17 (03) :251-263
[4]   The protein C pathway [J].
Esmon, C .
CRITICAL CARE MEDICINE, 2000, 28 (09) :S44-S48
[5]   Meta-analysis of controlled trials of anticoagulant therapies in patients with sepsis [J].
Freeman, BD ;
Zehnbauer, BA ;
Buchman, TG .
SHOCK, 2003, 20 (01) :5-9
[6]   Transcriptional profiling of interferon regulatory factor 3 target genes: Direct involvement in the regulation of interferon-stimulated genes [J].
Grandvaux, N ;
Servant, MJ ;
tenOever, B ;
Sen, GC ;
Balachandran, S ;
Barber, GN ;
Lin, RT ;
Hiscott, J .
JOURNAL OF VIROLOGY, 2002, 76 (11) :5532-5539
[7]  
Hack CE, 1997, ADV IMMUNOL, V66, P101, DOI 10.1016/S0065-2776(08)60597-0
[8]   Triggering the interferon response: The role of IRF-3 transcription factor [J].
Hiscott, J ;
Pitha, P ;
Genin, P ;
Nguyen, H ;
Heylbroeck, C ;
Mamane, Y ;
Algarte, M ;
Lin, RT .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1999, 19 (01) :1-13
[9]  
HUAI K, 1993, NATURE, V366, P580
[10]   The Jak-STAT pathway [J].
Imada, K ;
Leonard, WJ .
MOLECULAR IMMUNOLOGY, 2000, 37 (1-2) :1-11